Change currency
Enzymes in Drug Manufacturing (RBI00577)
Biocatalysis in pharmaceutical manufacturing is being driven by advances in enzyme and genomics technologies that are increasing the breadth of reaction applicability. The environmental benefits of enzymatic catalysis are also...
Mar 2011 £2,490
The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 (RBI00566)
Introduction This report provides a comprehensive overview of the global pharmaceutical fine chemicals market including the classification of PFCs, demand/supply dynamics, and the key deals and alliances in the PFC market....
Jan 2011£2,380€2,824$3,835
Global Growth Strategies for Chemical Companies (RBI00501)
Key trends, M&As, emerging markets and future outlookThe global chemical industry which is over $3 trillion in size had a major setback in 2009. The US economic recession, exacerbated by the credit crisis had spread to all...
Jul 2010£2,380€2,824$3,835
The Top 10 US Specialty Chemicals Companies (RBI00484)
Response to recession, growth strategies and SWOT analysisThe specialty chemicals operations of major US players remained relatively resilient during the downturn compared to their other business lines. The 2005-09 period also witnessed a considerable rise in consolidation...
Jul 2010£2,380€2,824$3,835
The Top 10 Global Fine Chemicals Companies (RBI00472)
Industry overview, key trends, growth strategies, financial performance, and SWOT analysisThe history of the fine chemicals industry dates back to the late 18th century, when the early chemical industry was evolved from natural dyes and explosives into modern pharmaceutical products....
May 2010£2,380€2,824$3,835
The Top 10 European Specialty Chemicals Companies (RBI00468)
Changing business models, strategies and SWOTsThe specialty chemicals operations of major European players remained relatively resilient during the economic downturn compared to their other business lines. The 2005-09 period witnessed a considerable rise in consolidation...
May 2010£2,380€2,824$3,835
The Global Active Pharmaceutical Ingredients (API) Market (RBI00404)
Evaluating challenges, opportunities, innovations and the market environmentActive pharmaceutical ingredients (APIs), also known as 'bulk drug substances', are defined by the US Food and Drugs Administration (FDA) as 'any substance or mixture of substances intended to be...
Feb 2010£2,380€2,824$3,835